Furthermore, miR-486 might inhibit cell growth of papillary thyroid carcinoma by targeting fibrillin-1 [34] and estrogen receptor-mediated miR-486 could regulate expression of OLFM4 in ovarian cancer [35]. Here, FBN1 is linked to differentiated thyroid carcinoma.